MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Oct 2023 Evaluate
A fair growth of 12.89% in the revenue at Rs. 9451.80 millions was reported in the September 2023 quarter as compared to Rs. 8372.30 millions during year-ago period.An average growth of 27.02% was recorded for the quarter ended September 2023 to Rs. 2123.60  millions from Rs. 1671.80 millions.Operating profit for the quarter ended September 2023 rose to 3258.10 millions as compared to 2391.00 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9451.80 8372.30 12.89 19597.60 16875.20 16.13 34112.70 31406.40 8.62
Other Income 521.60 783.70 -33.44 836.20 1137.90 -26.51 1327.50 1397.30 -5.00
PBIDT 3258.10 2391.00 36.27 6341.70 4608.30 37.61 8320.30 10306.20 -19.27
Interest 22.70 7.10 219.72 30.20 13.40 125.37 52.30 91.20 -42.65
PBDT 3235.40 2383.90 35.72 6311.50 4594.90 37.36 8268.00 10215.00 -19.06
Depreciation 330.40 318.00 3.90 652.80 625.50 4.36 1269.50 1209.60 4.95
PBT 2905.00 2065.90 40.62 5658.70 3969.40 42.56 6998.50 9005.40 -22.29
TAX 781.40 394.10 98.27 1414.70 793.90 78.20 1411.30 1806.80 -21.89
Deferred Tax 29.10 -61.10 -147.63 56.60 -79.40 -171.28 -29.30 95.10 -130.81
PAT 2123.60 1671.80 27.02 4244.00 3175.50 33.65 5587.20 7198.60 -22.38
Equity 252.70 257.10 -1.71 252.70 257.10 -1.71 252.70 171.70 47.18
PBIDTM(%) 34.47 28.56 20.70 32.36 27.31 18.50 24.39 32.82 -25.67
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..